Nuclear Medicine: Page 157

Navidea gets priority review for Lymphoseek expansion

By AuntMinnie.com staff writers

Navidea Biopharmaceuticals said the U.S. Food and Drug Administration has accepted its supplemental new drug application and granted priority review for an expanded use of its Lymphoseek imaging agent.

February 17, 2014

ACC, others call for patient-centric heart imaging

By Eric Barnes

Noninvasive cardiovascular imaging decisions must become more patient-centric and individualized, according to a statement from the American College of Cardiology (ACC) that was endorsed by 14 other medical societies.

February 17, 2014

PET, MRI show dementia-free people still at risk

By AuntMinnie.com staff writers

Dementia-free people who have two parents with Alzheimer's disease may show signs of the disease on PET and MRI brain scans decades before symptoms appear, according to a new study in Neurology.

February 13, 2014

BSGI is effective in women of all breast densities

By Kate Madden Yee

In a clinical trial inspired by the growing breast density awareness movement, researchers from Washington, DC, found that breast-specific gamma imaging (BSGI) is effective at identifying cancer in women of all breast densities, according to a paper in the February issue of the American Journal of Roentgenology.

February 12, 2014

ImaginAb teams with Duke-NUS

By AuntMinnie.com staff writers

ImaginAb has partnered with Duke-NUS Graduate Medical School Singapore to establish a laboratory to develop new in vivo molecular imaging agents.

February 11, 2014

FluoroPharma touts results for cardiac radiotracer

By AuntMinnie.com staff writers

FluoroPharma Medical is highlighting positive results presented this week for its CardioPET imaging agent.

February 6, 2014

FDG-PET/MRI shows advantages with malignant bone lesions

By Wayne Forrest

Compared to PET/CT, FDG-PET/MRI with a fully integrated whole-body scanner is "technically and clinically robust" in its evaluation of bone lesions, despite differences in attenuation correction between the two hybrid modalities, according to a study in the February issue of the Journal of Nuclear Medicine.

February 6, 2014

FDG-PET predicts risk in patients with cardiac sarcoidosis

By Wayne Forrest

In a large study of patients with known or suspected cardiac sarcoidosis, researchers found that FDG-PET could identify those at higher risk of death or life-threatening arrhythmia, according to results published in the February 4 issue of the Journal of the American College of Cardiology.

February 5, 2014

Eckert & Ziegler warns of lower profit in 2013 report

By AuntMinnie.com staff writers

Eckert & Ziegler has warned that its year-end 2013 financial report may be below expectations.

January 28, 2014

CAD uses MRI to differentiate brain tumors on FDG-PET

By Erik L. Ridley

A computer-aided detection (CAD) algorithm that makes use of anatomic data from MRI scans can help radiologists differentiate between benign and malignant brain tumors on FDG-PET images, according to researchers from Yamaguchi University in Japan.

January 28, 2014

Software helps rads agree when reading florbetapir PET scans

By Wayne Forrest

PET with the radiotracer florbetapir (also known as Amyvid) is an exciting new tool that could help determine which individuals are at risk of developing Alzheimer's disease. But reading the scans can be a challenge, so Pennsylvania researchers enlisted a software application that helped boost reader agreement.

January 26, 2014

Watpac to build Aussie Mo-99 facility

By AuntMinnie.com staff writers

Watpac has been awarded an $83 million contract to design and construct a molybdenum-99 (Mo-99) facility in Lucas Heights, New South Wales.

January 22, 2014

Previous Page

Page 157 of 440

Next Page